semaglutide percent weight loss Depicts the mean percentage of over time by medication Blog | Garland Sachse Wylie

People are experimenting clinically to see if spreading doses out or gradually tapering down can help maintain weight loss. That lack of FDA approval has not stopped interest from growing

However, theres a growing trend thats capturing attention both in clinical practice and popular culture: GLP-1 microdosing

Aging Cell 15 , 872884 (2016)

DOI: 10.1016/j.freeradbiomed.2013.11.029 Moratilla-Rivera, I., Perez-Jimenez, J., Ramos, S., et al

Explain the circumstanceswhether due to storage concerns, damage, or lossso your healthcare provider can document the need for early replacement

Research also suggests GLP-1 users are over two times more likely to experience GERD than those not taking the medication, and their risk of developing gallstones increases by nearly 50%